Alnylam Pharmace. buy klostergang
Start price
01.10.19
/
50%
€71.64
Target price
04.11.21
€150.00
Performance (%)
96.54%
End price
17.06.21
€140.80
Summary
This prediction ended on 17.06.21 with a price of €140.80. The BUY prediction by klostergang for Alnylam Pharmace. saw massive gains of 96.54%. klostergang has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Alnylam Pharmace. | 4.797% | 4.797% | -3.119% | 45.158% |
| iShares Core DAX® | -2,49 % | 0,32 % | 0,75 % | 51,02 % |
| iShares Nasdaq 100 | -4,40 % | 1,59 % | 32,09 % | 87,97 % |
| iShares Nikkei 225® | -4,29 % | 0,97 % | 50,00 % | 61,27 % |
| iShares S&P 500 | -2,20 % | 2,00 % | 22,60 % | 65,12 % |
Comments by klostergang for this prediction
In the thread Alnylam Pharmace. diskutieren
Buy mit Kursziel 130,0
Kursziel geändert auf 140,0
Kursziel geändert auf 150,0